Stocks● Neutral
SPIMACO Shareholders Approve 3.5% Dividend for 2025
SPIMACO's 2025 dividend of SAR 0.35 per share was approved by shareholders, matching last year's payout. The record date is pending, but the company's debt-free position supports steady returns.
Continue with
Shareholders of Saudi Pharmaceutical Industries & Medical Appliances Corp. (SPIMACO) approved a cash dividend for 2025 at 3.5% of capital, or SAR 0.35 per share, the company said in a filing to the Saudi stock exchange. The approval came at the annual general meeting.
The dividend is the same rate as the 2024 payout, reflecting steady cash generation from SPIMACO's drug distribution and medical equipment supply business. The company has paid a dividend every year since 2015. It operates across Saudi Arabia, serving public hospitals and private pharmacies, with a smaller manufacturing arm in Riyadh.